最高法院驳回终止联邦监狱跨性别者护理措施,为LGBTQ维权人士带来罕见胜利


2026年10月21日 美国东部时间上午11:29 / 美国有线电视新闻网(CNN)

作者:约翰·弗里策

更新于8分钟前
更新时间:2026年10月21日,美国东部时间上午11:36
发布时间:2026年10月21日,美国东部时间上午11:29

image
8月13日拍摄的美国最高法院大楼。

美国最高法院周三阻止了唐纳德·特朗普总统暂停联邦监狱内跨性别美国人的激素治疗及其他治疗措施的计划,这是保守派最高法院在跨性别权利议题上的罕见胜利。

最高法院以单句命令的形式公布了这一裁决,未对该决定作出解释。

自特朗普去年重新执政以来,最高法院已允许其政府禁止跨性别者参军,并批准了一项要求美国护照上的性别标注与旅行者出生时被指派的性别一致的政策。今年,最高法院还维持了禁止跨性别运动员参加女子运动队的州级法律。

此次最新的紧急上诉涉及特朗普在2024年竞选期间提出的一项议题,他当时通过一系列电视广告批评民主党候选人卡玛拉·哈里斯对待跨性别美国人的态度。特朗普重返白宫的第一天就签署了一项行政命令,禁止为“使囚犯外貌与异性相符”而实施“任何医疗程序、治疗或药物”。

美国联邦监狱局随后实施了一项政策,允许患有性别烦躁症的囚犯接受心理治疗和精神病学服务,但不包括激素治疗、手术或“社会适配服务”。后者可包括衣物、化妆品等物品。

美国哥伦比亚特区的一家地区法院和联邦上诉法院已临时阻止特朗普的这项政策生效。上个月,哥伦比亚特区巡回法院在一份简短命令中得出结论,认为政府的政策很可能是武断且反复无常的,因为联邦监狱局没有“充分”考虑“其在先前政策下提供性别确认护理的自身经验”。

在向最高法院提起的紧急上诉中,特朗普政府辩称,他们确实考虑了这一经验,且此前的治疗和适配措施“引发了安全和监狱管理方面的担忧,其严重性超过了这些措施可能带来的有限益处”。

三名声称多年来一直接受激素治疗的囚犯对该政策提出了质疑,认为这是对数十年来政策的突然改变,将导致近1000名在押人员终止治疗。美国公民自由联盟向最高法院表示,监狱方面提出的安全担忧十分“奇怪,因为联邦监狱局在过去30年里从未指出过一起与提供此类治疗相关的安全事件”。

两名保守派大法官——克拉伦斯·托马斯和塞缪尔·阿利托——对周三的命令提出了异议,但未说明理由。鉴于该案已完成案情陈述,且近两周来本就该作出裁决,这种未作解释的做法格外引人关注。

Supreme Court rejects ending trans care in federal prisons in rare win for LGBTQ advocates

2026-10-21 11:29 AM ET / CNN

By John Fritze

Updated 8 min ago

Updated Oct 21, 2026, 11:36 AM ET

PUBLISHED Oct 21, 2026, 11:29 AM ET

The Supreme Court building is seen on August 13.

Andrew Harnik/Getty Images

The Supreme Court on Wednesday blocked President Donald Trump from suspending hormone therapy and other treatments for transgender Americans in federal prisons, a rare win for transgender rights at the conservative high court.

The court handed down a one-sentence order that did not explain the decision.

Since Trump returned to power last year, the Supreme Court has allowed the administration to ban trans people from serving in the military and permitted a policy that requires that the sex designation on US passports align with a traveler’s sex assigned at birth. The court also this year upheld state laws that prohibit transgender athletes playing on girls’ sports teams.

The latest emergency appeal hit on an issue Trump raised during his 2024 campaign with a series of television advertisements that criticized Democratic nominee Kamala Harris for her approach to trans Americans. On his first day back in the White House, Trump signed an executive order barring “any medical procedure, treatment, or drug” for the purpose of “conforming an inmate’s appearance to that of the opposite sex.”

The Bureau of Prisons later implemented a policy that permits psychotherapy and psychiatry services for inmates with gender dysphoria, but not hormone therapies, surgeries or “social accommodations.” That can include items such as clothing and makeup.

A US district court and a federal appeals court in Washington, DC, blocked the Trump policy from taking effect in the short term. In a brief order last month, the DC Circuit concluded that the administration’s policy was likely arbitrary and capricious because the Bureau of Prisons had not “adequately” considered “its own experience providing gender-affirming care under its prior policy.”

In its emergency appeal to the Supreme Court, the Trump administration argued that it did consider that experience and that the previous treatment and accommodations “raised security and prison-administration concerns that outweighed whatever limited benefits they had.”

Three prisoners who said they had been receiving hormone therapy for years challenged the policy, arguing it was an abrupt change to decades of policy and would end treatment for nearly 1,000 people in custody. The assertion of security concerns within prisons, the American Civil Liberties Union told the Supreme Court, was odd “given that BOP has not pointed to a single security incident relating to its provision of this treatment over the past 30 years.”

Two conservative justices — Clarence Thomas and Samuel Alito — dissented from Wednesday’s order, but did not say why. The lack of explanation was particularly notable given that the case has been fully briefed and ripe for an order for almost two weeks.

评论

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注

湘ICP备2026001899号-2